Spending on prescription drugs that are covered under the medical benefit increased by 65% between 2014 and 2018 for commercial insurers and 40% for Medicare, according to Magellan Rx Management’s annual Medical Pharmacy Trend Report. A Magellan executive says the release of expensive new therapies — especially cancer drugs — is a main driver of price growth.
- Datapoint, Medicare and Medicaid
- Abstract, Health Plans
- People on the Move
- Medicare and Medicaid
- Datapoint, Drug Benefits